Mar 3, 2020 | Special Populations
Presented on October 5, 2018 Authors: Annette E. Whitney, MD – Digestive Health Associates of Texas, Dallas, TX; Harry E. Sarles, Jr., MD, FACG – DHAT Research Institute, Richardson, TX Claudia P. Schroeder, PharmD, PhD – Healix Infusion Therapy,... 
Mar 3, 2020 | Special Populations
Presented on October 4, 2017 Authors: Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc., Sugar Land, TX Richard M. Mandel, MD, FIDSA – University of Arizona College of Medicine, Tucson, AZ Ramesh V. Nathan, MD, FIDSA – Mazur, Statner,...Oct 25, 2019 | Clinical Outcomes, Special Populations
Selected as a Presidential Poster Harry E. Sarles – DHAT Research Institute, Richardson, TX Annette E. Whitney – Digestive Health Associates of Texas, Dallas, TX Samantha A. Kuten – Healix Infusion Therapy, Sugar Land, TX Lucinda J. Van Anglen...Oct 25, 2019 | Clinical Outcomes, Special Populations
Harry E. Sarles – DHAT Research Institute, Richardson, TX Annette E. Whitney – Digestive Health Associates of Texas, Dallas, TX Lucinda J. Van Anglen – Healix Infusion Therapy, Sugar Land, TX Samantha A. Kuten – Healix Infusion Therapy, Sugar...Oct 7, 2015 | Special Populations
Authors: Ramesh V. Nathan, MD, FIDSA – Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA Brian Metzger, MD, MPH – Austin Infectious Disease Consultants, Austin, TX Jorge R. Bernett, MD – Infectious Disease Doctors Medical Group, Walnut Creek, CA...
Recent Comments